Literature DB >> 16874484

Prenatal culture-based screening of Streptococcus agalactiae colonisation: resistance against erythromycin and clindamycin.

V Lavergne1, M Laverdière, A Duchesne, C Béliveau, J Delorme, A Di Zazzo, A C Labbé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16874484     DOI： 10.1007/s10096-006-0180-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  14 in total

1.  Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study.

Authors:  D De Mouy; J D Cavallo; R Leclercq; R Fabre
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Presence of mefA and mefE genes in Streptococcus agalactiae.

Authors:  C Arpin; H Daube; F Tessier; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

3.  Mechanisms of macrolide resistance in clinical group B streptococci isolated in France.

Authors:  F Fitoussi; C Loukil; I Gros; O Clermont; P Mariani; S Bonacorsi; I Le Thomas; D Deforche; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

4.  ACOG Committee Opinion: number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns.

Authors: 
Journal:  Obstet Gynecol       Date:  2002-12       Impact factor: 7.661

5.  Prevalence and mechanisms of erythromycin resistance in group A and group B Streptococcus: implications for reporting susceptibility results.

Authors:  M Desjardins; K L Delgaty; K Ramotar; C Seetaram; B Toye
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

6.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

7.  Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.

Authors:  J C de Azavedo; M McGavin; C Duncan; D E Low; A McGeer
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

8.  Genotypic characterization of macrolide-resistant strains of Streptococcus pneumoniae isolated in Quebec, Canada, and in vitro activity of ABT-773 and telithromycin.

Authors:  K Weiss; C Guilbault; L Cortes; C Restieri; D E Low
Journal:  J Antimicrob Chemother       Date:  2002-09       Impact factor: 5.790

9.  Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC.

Authors:  Stephanie Schrag; Rachel Gorwitz; Kristi Fultz-Butts; Anne Schuchat
Journal:  MMWR Recomm Rep       Date:  2002-08-16

10.  Group B streptococcal antibiotic resistance patterns in pregnant women.

Authors:  Robert J Stiller; Linda Padilla; Ronika Choudhary; Thomas Tinghitella; Steven Laifer
Journal:  Conn Med       Date:  2003 Jun-Jul
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.